Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) Debt to equity

Alert me on Debt to equity

Medtronic PLC's debt to equity at the end of the quarter to 31 July 2026 was 0.6×, down 0.0× from fiscal 2026 (0.6×). Over the past ten years it has ranged from 0.5× (fiscal 2022) to 0.7× (fiscal 2015); the current reading is higher than 67% of that period. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2026 0.6× (5.50%)
FY2025 0.6× 19.06%
FY2024 0.5× 5.24%
FY2023 0.5× 3.10%
FY2022 0.5× (10.56%)
FY2021 0.5× 4.92%
FY2020 0.5× (3.35%)
FY2019 0.5× (0.49%)
FY2018 0.5× (23.72%)
FY2017 0.7× 11.22%

Quarterly newest first

Period Debt to equity Change
Jul 2026 0.6× (0.86%)
Apr 2026 0.6× (2.14%)
Jan 2026 0.6× (4.20%)
Oct 2025 0.6× 0.20%
43 more quarters

Against its own ten years

Low 0.5× High 0.7×
Ten-year median 0.5×
Current reading's percentile 67

Debt to equity against peers

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on MDT